ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
Dow Jones
42.801,72
0,52%
Euro vs US Dollar
1,0832
-0,01%
Bitcoin
86.503,30
-0,29%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) News

BNTX

BioNTech (BNTX)

BioNTech SE
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DatumZeitQuelleÜberschriftSymbolFirma
04/03/202522h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
27/02/202513h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
24/02/202512h45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025NASDAQ:BNTXBioNTech SE
20/02/202513h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
20/02/202513h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
04/02/202517h15IH Market NewsModerna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s NominationNASDAQ:BNTXBioNTech SE
03/02/202513h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
03/02/202512h45GlobeNewswire Inc.BioNTech Completes Acquisition of BiotheusNASDAQ:BNTXBioNTech SE
14/01/202512h58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
14/01/202512h45GlobeNewswire Inc.BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BNTXBioNTech SE
27/12/202413h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
27/12/202413h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/12/202423h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
13/12/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
11/12/202423h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
10/12/202400h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
06/12/202423h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
27/11/202423h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
27/11/202400h37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
25/11/202423h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
15/11/202423h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
14/11/202413h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/11/202423h00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BNTXBioNTech SE
13/11/202412h49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
13/11/202412h45GlobeNewswire Inc.BioNTech to Acquire Biotheus to Boost Oncology StrategyNASDAQ:BNTXBioNTech SE
12/11/202413h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
04/11/202412h57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
04/11/202412h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
04/11/202412h45GlobeNewswire Inc.BioNTech Announces Third Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
31/10/202412h45GlobeNewswire Inc.BioNTech to Host Innovation Series R&D Day on November 14, 2024NASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX

Kürzlich von Ihnen besucht

BOV
SOJA3Q
Boa Safra Sementes ON
BIT
S31342
Societe Generale Effekten
AMEX
MON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten